Indication
Protection Against COVID-19
1 clinical trial
1 product
Product
BNT162b3Clinical trial
A Multi-site, Phase I/II, 2-Part, Dose-Escalation Trial Investigating the Safety and Immunogenicity of a Prophylactic SARS-CoV-2 RNA Vaccine (BNT162b3) Against COVID-19 Using Different Dosing Regimens in Healthy AdultsStatus: Completed, Estimated PCD: 2021-03-12